Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation ; volume:265 ; number:5 ; day:6 ; month:3 ; year:2018 ; pages:1115-1122 ; date:5.2018
Journal of neurology ; 265, Heft 5 (6.3.2018), 1115-1122, 5.2018
- Urheber
-
Tallantyre, E. C.
- Beteiligte Personen und Organisationen
-
Whittam, D. H.
Jolles, S.
Paling, D.
Constantinesecu, C.
Robertson, N. P.
Jacob, A.
SpringerLink (Online service)
- DOI
-
10.1007/s00415-018-8812-0
- URN
-
urn:nbn:de:101:1-2018070722453097630612
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tallantyre, E. C.
- Whittam, D. H.
- Jolles, S.
- Paling, D.
- Constantinesecu, C.
- Robertson, N. P.
- Jacob, A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Genetics of primary antibody deficiency
Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Genetics of primary antibody deficiency
Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Genetics of primary antibody deficiency
Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody